Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Sudarshan Pharma Ind
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Sudarshan Pharma Ind

WEBSITE BSE:543828 NSE: SUDARSHAN Inc. Year: 2008 Industry: Pharmaceuticals & Drugs My Bucket: Add Stock

₹30.3 -0 | 0.1%

Last updated: 11:12

Consolidated Standalone

Last updated: 11:12

Sudarshan Pharma Ind Overview

Sudarshan Pharma Industries Ltd is a prominent pharmaceutical company renowned for its high-quality and innovative healthcare solutions. With a steadfast commitment to advancing medical care, the company specializes in the research, development, and manufacturing of a diverse range of pharmaceutical products. Its comprehensive portfolio encompasses prescription medications, over-the-counter drugs, and healthcare essentials. Sudarshan Pharma Industries Ltd is dedicated to upholding rigorous quality standards, ensuring the safety and efficacy of ...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Sudarshan Pharma Ind Key Financials

Market Cap ₹728 Cr.

Stock P/E 45.6

P/B 5.1

Current Price ₹30.3

Book Value ₹ 6

Face Value 1

52W High ₹35.2

Dividend Yield 0%

52W Low ₹ 18.5

Edit Ratio

Sudarshan Pharma Ind Share Price

₹ | |

Volume
Price

Sudarshan Pharma Ind Quarterly Price

Quarterly Monthly
Show Value Show %

Sudarshan Pharma Ind Peer Comparison

Sudarshan Pharma Ind Quarterly Results

#(Fig in Cr.) Jun 2024 Sep 2024 Dec 2024 Jun 2025 Sep 2025 Dec 2025
Net Sales 99 129 116 145 169 168
Other Income 1 0 1 1 2 2
Total Income 100 129 116 146 171 170
Total Expenditure 97 116 108 134 160 157
Operating Profit 3 13 8 12 11 12
Interest 4 4 4 6 6 6
Depreciation 1 1 1 1 1 1
Exceptional Income / Expenses 0 -1 0 0 0 0
Profit Before Tax -2 8 4 5 4 5
Provision for Tax -0 2 1 1 0 1
Profit After Tax -1 6 3 4 4 4
Adjustments 0 0 0 0 0 0
Profit After Adjustments -1 6 3 4 4 4
Adjusted Earnings Per Share -0 0.2 0.1 0.2 0.2 0.2

Sudarshan Pharma Ind Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 193 357 461 464 505 598
Other Income 0 0 1 3 3 6
Total Income 194 358 462 466 508 603
Total Expenditure 186 346 447 441 465 559
Operating Profit 8 11 16 25 42 43
Interest 3 3 5 9 16 22
Depreciation 1 1 1 1 2 4
Exceptional Income / Expenses 0 0 0 0 -3 0
Profit Before Tax 4 7 9 15 22 18
Provision for Tax 1 2 2 4 6 3
Profit After Tax 3 5 7 11 16 15
Adjustments 0 -0 0 0 0 0
Profit After Adjustments 3 5 7 11 16 15
Adjusted Earnings Per Share 0.3 0.5 0.3 0.5 0.7 0.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 12% 0% 0%
Operating Profit CAGR 68% 56% 0% 0%
PAT CAGR 45% 47% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 7% 62% NA% NA%
ROE Average 13% 12% 13% 13%
ROCE Average 14% 14% 15% 15%

Sudarshan Pharma Ind Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 23 30 101 112 131
Minority's Interest 0 0 0 0 0
Borrowings 5 5 13 10 10
Other Non-Current Liabilities 0 0 0 0 1
Total Current Liabilities 71 103 118 160 260
Total Liabilities 99 138 232 283 402
Fixed Assets 6 6 20 26 24
Other Non-Current Assets 5 1 14 20 44
Total Current Assets 88 130 199 237 335
Total Assets 99 138 232 283 402

Sudarshan Pharma Ind Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 1 0 12 0
Cash Flow from Operating Activities 3 -4 -29 8 35
Cash Flow from Investing Activities -1 -1 -26 -7 -20
Cash Flow from Financing Activities -1 4 66 -12 -14
Net Cash Inflow / Outflow -0 -1 11 -12 0
Closing Cash & Cash Equivalent 1 0 12 0 1

Sudarshan Pharma Ind Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.28 0.54 0.29 0.48 0.66
CEPS(Rs) 0.36 0.63 0.33 0.53 0.76
DPS(Rs) 0 0 0.03 0 0
Book NAV/Share(Rs) 2.36 3.05 4.2 4.64 5.3
Core EBITDA Margin(%) 3.71 3.06 3.18 4.92 7.9
EBIT Margin(%) 3.52 2.94 3.23 5.21 7.41
Pre Tax Margin(%) 1.85 2 2.06 3.29 4.28
PAT Margin (%) 1.38 1.47 1.53 2.47 3.16
Cash Profit Margin (%) 1.77 1.71 1.72 2.74 3.6
ROA(%) 2.69 4.43 3.8 4.44 4.65
ROE(%) 11.87 20.08 10.76 10.77 13.33
ROCE(%) 13.01 18.67 15.25 13.75 14.42
Receivable days 114.01 68.42 61.31 80.34 102.16
Inventory Days 45.24 36.2 48.04 63.12 81.75
Payable days 90.88 64.25 70.18 64.12 62.07
PER(x) 0 0 19.08 15.57 46.06
Price/Book(x) 0 0 1.33 1.6 5.76
Dividend Yield(%) 0 0 0.54 0 0
EV/Net Sales(x) 0.2 0.11 0.34 0.61 1.79
EV/Core EBITDA(x) 5.05 3.52 9.91 11.14 21.33
Net Sales Growth(%) 0 84.69 29.19 0.48 8.95
EBIT Growth(%) 0 54.63 41.69 62.25 54.72
PAT Growth(%) 0 96.49 34.07 62.79 39.26
EPS Growth(%) 0 92.34 -45.68 62.8 39.29
Debt/Equity(x) 1.32 1.03 0.34 0.94 1.34
Current Ratio(x) 1.23 1.26 1.68 1.48 1.29
Quick Ratio(x) 0.89 0.81 1.05 0.94 0.75
Interest Cover(x) 2.11 3.11 2.76 2.7 2.37
Total Debt/Mcap(x) 0 0 0.25 0.59 0.23

Sudarshan Pharma Ind Shareholding Pattern

# Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 57.39 57.39 57.39 57.39 57.39 57.39 57.39 57.39 57.39
FII 3.58 1.4 1.4 13.07 18.45 19.48 20.79 19.78 19.95
DII 0 0 0 0 0 0.05 0.05 0.05 0.05
Public 39.03 41.21 41.21 29.54 24.16 23.07 21.77 22.78 22.61
Others 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100

Sudarshan Pharma Ind News

Sudarshan Pharma Ind Pros & Cons

Pros

  • Debtor days have improved from 64.12 to 62.07days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Company has a low return on equity of 12% over the last 3 years.
  • Stock is trading at 5.1 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!